Skip to main content

Articles

Page 42 of 48

  1. Increased fasting plasma glucose (FPG), which includes impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and diabetes, is a risk factor for arterial stiffness. While IFG is widely accepted as a...

    Authors: Jin Young Shin, Hye Ree Lee and Duk Chul Lee
    Citation: Cardiovascular Diabetology 2011 10:30
  2. Left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular disease and is common among patients with type 2 diabetes. However, no systematic screening for LVH is currently recommended for patie...

    Authors: Jithendra B Somaratne, Gillian A Whalley, Katrina K Poppe, Mariska M ter Bals, Gina Wadams, Ann Pearl, Warwick Bagg and Rob N Doughty
    Citation: Cardiovascular Diabetology 2011 10:29
  3. N-terminal-pro-brain natriuretic peptide (NT-proBNP) is elevated in gestational hypertension and preeclampsia. This trial aimed to generate data for gestational diabetes mellitus patients, who are at risk to d...

    Authors: Martin Andreas, Harald Zeisler, Ammon Handisurya, Maximilian B Franz, Michael Gottsauner-Wolf, Michael Wolzt and Alexandra Kautzky-Willer
    Citation: Cardiovascular Diabetology 2011 10:28
  4. Several studies have shown that common variants in the MTNR1B gene were associated with fasting glucose level and type 2 diabetes. The purpose of this study was to examine whether tagging single nucleotide polymo...

    Authors: Yan Ling, Xiaomu Li, Qian Gu, Hongyan Chen, Daru Lu and Xin Gao
    Citation: Cardiovascular Diabetology 2011 10:27
  5. Although clinical diabetes mellitus is obviously a high risk factor for myocardial infarction (MI), in experimental studies disagreement exists about the sensitivity to ischemic injury of an infarcted myocardi...

    Authors: Bruno Rodrigues, Kaleizu T Rosa, Alessandra Medeiros, Beatriz D Schaan, Patricia C Brum, Kátia De Angelis and Maria Cláudia Irigoyen
    Citation: Cardiovascular Diabetology 2011 10:26
  6. Aspirin has been recommended for the prevention of major adverse cardiovascular events (MACE, composite of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) in diabetic patients with...

    Authors: Sonia Butalia, Alexander A Leung, William A Ghali and Doreen M Rabi
    Citation: Cardiovascular Diabetology 2011 10:25
  7. Hypertension, diabetes and obesity are not isolated findings, but a series of interacting interactive physiologic derangements. Taking into account genetic background and lifestyle behavior, AI (autonomic imba...

    Authors: Leandro Boer-Martins, Valéria N Figueiredo, Caroline Demacq, Luiz C Martins, Fernanda Consolin-Colombo, Márcio J Figueiredo, Fernando PS Cannavan and Heitor Moreno Jr
    Citation: Cardiovascular Diabetology 2011 10:24
  8. Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated wi...

    Authors: Zaid Al-Hamodi, Ikram S Ismail, Riyadh Saif-Ali, Khaled A Ahmed and Sekaran Muniandy
    Citation: Cardiovascular Diabetology 2011 10:23
  9. It is important for patients that treatments for diabetes not increase cardiovascular (CV) risk. The objective of this analysis was to examine retrospectively the CV safety of exenatide BID, a GLP-1 receptor a...

    Authors: Robert Ratner, Jenny Han, Dawn Nicewarner, Irina Yushmanova, Byron J Hoogwerf and Larry Shen
    Citation: Cardiovascular Diabetology 2011 10:22
  10. Although European guidelines advise oral glucose tolerance test (OGTT) in patients with acute myocardial infarction (AMI) before or shortly after hospital discharge, data supporting this recommendation are inc...

    Authors: Agata Bronisz, Marek Kozinski, Przemyslaw Magielski, Tomasz Fabiszak, Joanna Gierach, Iwona Swiatkiewicz, Adam Sukiennik, Aldona Kubica, Marek Bronisz, Zofia Grabczewska, Anna Sinkiewicz, Roman Junik and Jacek Kubica
    Citation: Cardiovascular Diabetology 2011 10:21
  11. Apolipoprotein B100 (apoB) is a superior indicator of CV risk than total or LDL-C. Non-HDL-C represents a simple surrogate for apoB in hypertriglyceridemic and/or T2DM patients. ApoB and non-HDL-C show high corre...

    Authors: Michel P Hermans, Frank M Sacks, Sylvie A Ahn and Michel F Rousseau
    Citation: Cardiovascular Diabetology 2011 10:20
  12. Glucose variability is one of components of the dysglycemia in diabetes and may play an important role in development of diabetic vascular complications. The objective of this study was to assess the relations...

    Authors: Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou and Changsheng Ma
    Citation: Cardiovascular Diabetology 2011 10:19
  13. Type 2 diabetes (T2D) is strongly associated with cardiovascular risk and requires medications that improve glycemic control and other cardiovascular risk factors. The authors aimed to assess the relative effe...

    Authors: Ángel Rodríguez, Jesús Reviriego, Vasilios Karamanos, Francisco J del Cañizo, Nikolaos Vlachogiannis and Vangelis Drossinos
    Citation: Cardiovascular Diabetology 2011 10:18
  14. The biological mechanisms in the association between the metabolic syndrome (MS) and various biomarkers, such as 25-hydroxyvitamin D (vit D) and magnesium, are not fully understood. Several of the proposed pre...

    Authors: Jo Røislien, Ben Van Calster and Jøran Hjelmesæth
    Citation: Cardiovascular Diabetology 2011 10:17
  15. Elevated plasma levels of asymmetric dimethylarginine (ADMA) has been reported to be associated with insulin resistance and micro/macrovascular diabetic complications, and may predict cardiovascular events in ...

    Authors: Tse-Min Lu, Shing-Jong Lin, Ming-Wei Lin, Chiao-Po Hsu and Ming-Yi Chung
    Citation: Cardiovascular Diabetology 2011 10:16
  16. To assess heart failure therapies in diabetic patients with preserved as compared to impaired systolic ventricular function.

    Authors: Frank Edelmann, Rolf Wachter, Hans-Dirk Düngen, Stefan Störk, Annette Richter, Raoul Stahrenberg, Till Neumann, Claus Lüers, Christiane E Angermann, Felix Mehrhof, Götz Gelbrich and Burkert Pieske
    Citation: Cardiovascular Diabetology 2011 10:15
  17. Adiponectin has insulin-sensitizing and anti-atherosclerotic effects, partly mediated through its action on monocytes. We aimed to determine adiponectin levels and expression of its receptors (AdipoR1 and Adip...

    Authors: Anastasios Kollias, Panayoula C Tsiotra, Ignatios Ikonomidis, Eirini Maratou, Panayota Mitrou, Erifyli Kyriazi, Eleni Boutati, John Lekakis, Theofanis Economopoulos, Dimitrios T Kremastinos, George Dimitriadis and Sotirios A Raptis
    Citation: Cardiovascular Diabetology 2011 10:14
  18. Diabetes mellitus has emerged as one of the main alarms to human health in the 21st century. Pronounced changes in the human environment, behavior and lifestyle have accompanied globalization, which resulted i...

    Authors: Edite Teixeira-Lemos, Sara Nunes, Frederico Teixeira and Flávio Reis
    Citation: Cardiovascular Diabetology 2011 10:12
  19. The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone has been suggested to exert cardiovascular protection through the improvement of lipid metabolism, anti-inflammation, anti-prolife...

    Authors: Liqun Ren, Naifeng Liu, Hong Zhi, Yingjuan Li, Yanzhi Li, Rining Tang and Zulong Sheng
    Citation: Cardiovascular Diabetology 2011 10:10
  20. Given the elevated risk of cardiovascular events and the higher prevalence of silent coronary artery disease (CAD) in diabetic versus non-diabetic patients, the need to screen asymptomatic diabetic patients fo...

    Authors: Cristina Hernández, Jaume Candell-Riera, Andreea Ciudin, Gemma Francisco, Santiago Aguadé-Bruix and Rafael Simó
    Citation: Cardiovascular Diabetology 2011 10:9
  21. Adiponectin and resistin are adipokines which modulate insulin action, energy, glucose and lipid homeostasis. Meta-analyses showed that hypoadiponectinemia and hyperresistinemia are strongly associated with in...

    Authors: Cia-Hin Lau and Sekaran Muniandy
    Citation: Cardiovascular Diabetology 2011 10:8
  22. Glycemic control and management of dyslipidemia to reduce cardiovascular risk are major therapeutic goals in individuals with type 2 diabetes mellitus (T2DM). This study was performed to evaluate the effects o...

    Authors: Barbara C Hansen, Xenia T Tigno, Agnes Bénardeau, Markus Meyer, Elena Sebokova and Jacques Mizrahi
    Citation: Cardiovascular Diabetology 2011 10:7
  23. Glucagon-like peptide-1 (GLP-1) is a hormone predominately synthesized and secreted by intestinal L-cells. GLP-1 modulates multiple cellular functions and its receptor agonists are now used clinically for diab...

    Authors: Yong-Fu Xiao, Alena Nikolskaya, Deborah A Jaye and Daniel C Sigg
    Citation: Cardiovascular Diabetology 2011 10:6
  24. Type 2 diabetes is a well-established risk factor for cardiovascular disease and is common among patients with acute myocardial infarction (MI). The extent to which patients with first-time MI develop diabetes...

    Authors: Mette L Norgaard, Charlotte Andersson, Peter Riis Hansen, Søren S Andersen, Allan Vaag, Tina K Schramm, Fredrik Folke, Lars Køber, Christian Torp-Pedersen and Gunnar H Gislason
    Citation: Cardiovascular Diabetology 2011 10:5
  25. Diabetic cardiomyopathy, characterized by myocardial structural and functional changes, is a specific cardiomyopathy develops in patients with diabetes mellitus. The present study was to investigate the role o...

    Authors: Dongdong Sun, Min Shen, Jiayi Li, Weijie Li, Yingmei Zhang, Li Zhao, Zheng Zhang, Yuan Yuan, Haichang Wang and Feng Cao
    Citation: Cardiovascular Diabetology 2011 10:4
  26. We examined the relationship between the intima-media thickness of the common carotid artery (CCA-IMT) and arterial stiffness, assessed by pulse wave velocity (PWV), the ambulatory arterial stiffness index (AA...

    Authors: Manuel Ángel Gómez-Marcos, José Ignacio Recio-Rodríguez, María Carmen Patino-Alonso, Cristina Agudo-Conde, Leticia Gómez-Sánchez, Emiliano Rodríguez-Sánchez, Carlos Martín-Cantera and Luís García-Ortiz
    Citation: Cardiovascular Diabetology 2011 10:3
  27. Disorders of endocrine substances in epicardial adipose tissue are known causes of coronary artery disease (CAD). Adiponectin is associated with cardiovascular disease. However, expression of adiponectin in ep...

    Authors: Yuan Zhou, Yutao Wei, Lei Wang, Xianguo Wang, Xinling Du, Zongquan Sun, Nianguo Dong and Xinzhong Chen
    Citation: Cardiovascular Diabetology 2011 10:2
  28. To estimate the incidence of complications, life expectancy and diabetes related mortality in the Mexican diabetic population over the next two decades using data from a nation-wide, population based survey an...

    Authors: Nancy Reynoso-Noverón, Roopa Mehta, Paloma Almeda-Valdes, Rosalba Rojas-Martinez, Salvador Villalpando, Mauricio Hernández-Ávila and Carlos A Aguilar-Salinas
    Citation: Cardiovascular Diabetology 2011 10:1
  29. Diabetes mellitus counts as a major risk factor for developing atherosclerosis. The activation of protein kinase C (PKC) is commonly known to take a pivotal part in the pathogenesis of atherosclerosis, though ...

    Authors: Dieter Paul Hoyer, Yüksel Korkmaz, Sabine Grönke, Klaus Addicks, Nina Wettschureck, Stefan Offermanns and Hannes Reuter
    Citation: Cardiovascular Diabetology 2010 9:93
  30. There is debate as to whether the association between C-reactive protein (CRP) and insulin resistance is independent of body fatness, particularly central obesity. Therefore, the association among CRP, insulin...

    Authors: Bin Lu, Yehong Yang, Zhihong Yang, Xiaocheng Feng, Xuanchun Wang, Zhaoyun Zhang and Renming Hu
    Citation: Cardiovascular Diabetology 2010 9:92
  31. Plaque morphology directly correlates with risk of embolism and the recently developed dual-source computed tomography angiography (DSCTA) may help to detect plaques more precisely. The aim of our study was to...

    Authors: Ci He, Zhi-gang Yang, Zhi-gang Chu, Zhi-hui Dong, Heng Shao, Wen Deng, Jing Chen, Li-qing Peng, Si-shi Tang and Jia-he Xiao
    Citation: Cardiovascular Diabetology 2010 9:91
  32. Endothelial inflammatory responses mediated by Toll-like receptors (TLRs), particularly TLR2 and TLR4, play an important role in atherogenesis. While Type 1 diabetes (T1D) promotes the development and progress...

    Authors: Jilin Li, Chunhua Jin, Joseph C Cleveland Jr, Lihua Ao, Dingli Xu, David A Fullerton and Xianzhong Meng
    Citation: Cardiovascular Diabetology 2010 9:90
  33. The aim of the present study was to verify whether BNP might detect pre-clinical diastolic dysfunction (LVDD) in type-2 diabetic patients.

    Authors: Silvio Romano, Michele Di Mauro, Simona Fratini, Leonello Guarracini, Fabrizio Guarracini, Gianfranco Poccia and Maria Penco
    Citation: Cardiovascular Diabetology 2010 9:89
  34. T2DM is associated with atherogenic dyslipidemia (AD), defined as decreased HDL-C plus raised triglycerides (TG). AD confers increased risk for CAD, even when LDL-C is at target. AD is rarely assessed due to l...

    Authors: Michel P Hermans, Sylvie A Ahn and Michel F Rousseau
    Citation: Cardiovascular Diabetology 2010 9:88
  35. Metabolic syndrome (MetS) is associated with an increased risk of major cardiovascular events. Increased high-sensitivity C-reactive protein (hsCRP) levels are associated with MetS and its components. Changes ...

    Authors: Ryuichi Kawamoto, Yasuharu Tabara, Katsuhiko Kohara, Tetsuro Miki, Tomo Kusunoki, Shuzo Takayama, Masanori Abe, Tateaki Katoh and Nobuyuki Ohtsuka
    Citation: Cardiovascular Diabetology 2010 9:87
  36. Low grade inflammation is of pathogenic importance in atherosclerosis and in the development of cardiovascular disease (CVD) and type 2 diabetes (T2D). Matrix GLA protein (MGP), an inhibitor of medial calcific...

    Authors: Stine B Thomsen, Camilla N Rathcke, Bo Zerahn and Henrik Vestergaard
    Citation: Cardiovascular Diabetology 2010 9:86
  37. Insulin resistance (IR) has been associated with cardiovascular diseases (CVD). Heart rate variability (HRV), an index of cardiac autonomic modulation (CAM), is also associated with CVD mortality and CVD morbi...

    Authors: Sol M Rodríguez-Colón, Xian Li, Michele L Shaffer, Fan He, Edward O Bixler, Alexandros N Vgontzas, Jianwen Cai and Duanping Liao
    Citation: Cardiovascular Diabetology 2010 9:85
  38. To investigate whether the known diabetes mellitus (KDM) or newly diagnosed diabetes mellitus (NDM) could be regarded as a coronary heart disease (CHD) risk equivalent among a relatively young Middle East popu...

    Authors: Farzad Hadaegh, Nooshin Fahimfar, Davood Khalili, Farhad Sheikholeslami and Fereidoun Azizi
    Citation: Cardiovascular Diabetology 2010 9:84
  39. Notwithstanding previous studies supporting independent associations between obstructive sleep apnea (OSA) and prevalence of diabetes, the underlying pathogenesis of impaired glucose regulation in OSA remains ...

    Authors: Maria Pallayova, Kimberley E Steele, Thomas H Magnuson, Michael A Schweitzer, Nathan R Hill, Shannon Bevans-Fonti and Alan R Schwartz
    Citation: Cardiovascular Diabetology 2010 9:83
  40. Azelnidipine (AZL), a long-acting dihydropyridine-based calcium antagonist, has been recently approved and used for treating ischemic heart disease and cardiac remodeling after myocardial infarction, however, ...

    Authors: Vasundhara Kain, Sandeep Kumar, Amrutesh S Puranik and Sandhya L Sitasawad
    Citation: Cardiovascular Diabetology 2010 9:82
  41. Higher walking levels lead to lower mortality in type 2 diabetes, but inclement weather may reduce walking. In this patient population, we conducted a longitudinal cohort study to objectively quantify seasonal...

    Authors: Kaberi Dasgupta, Lawrence Joseph, Louise Pilote, Ian Strachan, Ron J Sigal and Cathy Chan
    Citation: Cardiovascular Diabetology 2010 9:81
  42. Diabetics have high prevalence of subclinical coronary artery disease (CAD) with typical characteristics (diffuse disease, large calcifications). Although 64-slice multidetector computed tomography (MDCT) coro...

    Authors: Daniele Andreini, Gianluca Pontone, Antonio L Bartorelli, Piergiuseppe Agostoni, Saima Mushtaq, Laura Antonioli, Sarah Cortinovis, Mauro Canestrari, Andrea Annoni, Giovanni Ballerini, Cesare Fiorentini and Mauro Pepi
    Citation: Cardiovascular Diabetology 2010 9:80
  43. Recent studies revealed that glucokinase regulatory protein (GCKR) variants (rs780094 and rs1260326) are associated with serum triglycerides and plasma glucose levels. Here we analyzed primarily the associatio...

    Authors: Márton Mohás, Péter Kisfali, Luca Járomi, Anita Maász, Eszter Fehér, Veronika Csöngei, Noémi Polgár, Enikő Sáfrány, Judit Cseh, Katalin Sümegi, Katalin Hetyésy, István Wittmann and Béla Melegh
    Citation: Cardiovascular Diabetology 2010 9:79
  44. The various autonomic control systems lead to characteristic changes in heart rate (HR) and blood pressure (BP) during acute hemorrhage. However, cardiovascular autonomic neuropathy due to diabetes mellitus ma...

    Authors: Aiji Boku, Mitsutaka Sugimura, Yoshinari Morimoto, Hiroshi Hanamoto and Hitoshi Niwa
    Citation: Cardiovascular Diabetology 2010 9:78
  45. Dyslipidaemia is an important but modifiable risk factor of cardiovascular disease (CVD) in type 2 diabetes. Yet, the effectiveness of lipid regulating drugs in Asians is lacking. We examined the effects of li...

    Authors: Rose ZW Ting, Xilin Yang, Linda WL Yu, Andrea OY Luk, Alice PS Kong, Peter CY Tong, Wing-Yee So, Juliana CN Chan and Ronald CW Ma
    Citation: Cardiovascular Diabetology 2010 9:77
  46. Accumulating evidence suggests glucagon-like peptide-1 (GLP-1) exerts cardioprotective effects in animal models of myocardial infarction (MI). We hypothesized that chronic treatment with GLP-1 or the exenatide...

    Authors: Que Liu, Christen Anderson, Anatoly Broyde, Clara Polizzi, Rayne Fernandez, Alain Baron and David G Parkes
    Citation: Cardiovascular Diabetology 2010 9:76
  47. Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are risk factors for acute myocardial infarction (AMI). However, it is unknown whether hyperglycemic state is associated with increased major adverse...

    Authors: Shuichi Kitada, Yoritaka Otsuka, Nobuaki Kokubu, Yoichiro Kasahara, Yu Kataoka, Teruo Noguchi, Yoichi Goto, Genjirou Kimura and Hiroshi Nonogi
    Citation: Cardiovascular Diabetology 2010 9:75
  48. Coronary artery disease (CAD) is a common and severe complication of type 2 diabetes mellitus (DM). The aim of this study is to identify the features of CAD in diabetic patients using coronary CT angiography (...

    Authors: Zhi-gang Chu, Zhi-gang Yang, Zhi-hui Dong, Zhi-yu Zhu, Li-qing Peng, Heng Shao, Ci He, Wen Deng, Si-shi Tang and Jing Chen
    Citation: Cardiovascular Diabetology 2010 9:74

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics